{"symbol": "SESN", "companyName": "Sesen Bio Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.sesenbio.com", "description": "Sesen Bio Inc is a late-stage clinical company engaged in next-generation antibody-drug conjugate therapies for the treatment of cancer based on the company's Targeted Protein Therapeutics platform.", "CEO": "Thomas R. Cannell", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}